SpyGlass Pharma SGP
NASDAQ SGP
$25.44 -0.54 (-2.08%)
At close: Sep 29, 2026 · 4:00 PM EDT

SpyGlass Pharma (SGP) Total Current Liabilities (2024 - 2026)

Updated

SpyGlass Pharma (SGP) recorded Total Current Liabilities of $9.44 million in Q2 2026.

Analysis

SpyGlass Pharma (SGP) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, SpyGlass Pharma reported Total Current Liabilities of $8.58 million, up 10.2% from FY2024.

  • Across earlier years, Total Current Liabilities came in at $7.79 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 SpyGlass Pharma 868.94 Mn 868.94 Mn - 9.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.44 Mn
Dec 31, 2025 8.58 Mn
Dec 31, 2024 7.79 Mn
API Access

SpyGlass Pharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SGP&period=max&api_key=YOUR_API_KEY